logo
    Is serotonin involved in hypothermic effect and its tolerance development of Δ8-tetrahydrocannabinol and 11-hydroxy-Δ8-tetrahydrocannabinol in the mouse?
    Kazuhito WatanabeIkuo YamamotoS. NarimatsuHidetoshi Yoshimura
    0
    Citation
    0
    Reference
    20
    Related Paper
    Keywords:
    Tetrahydrocannabinol
    Δ9-tetrahydrocannabinol
    Delta-9-tetrahydrocannabinol
    Dronabinol
    Topics:
    Neuroscience of respiration and sleep
    Cannabis and Cannabinoid Research
    Diet, Metabolism, and Disease
    Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
    European Journal of Pharmacology (1997)
    Thomas H. BurkeyRaymond M. QuockPaul ConsroeFrederick J. EhlertYoshiaki Hosohata
    Anandamide
    Rimonabant
    Tetrahydrocannabinol
    Cannabinoid Receptor Agonists
    Delta-9-tetrahydrocannabinol
    GTPgammaS
    Citations (94)
    FAAH−/− Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After Δ9-Tetrahydrocannabinol and Anandamide Administration
    Neuropsychopharmacology (2010)
    Katherine W. FalenskiAndrew ThorpeJoel E. SchlosburgBenjamin F. CravattRehab A. Abdullah
    Anandamide
    Rimonabant
    AM251
    Citations (81)
    Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse
    S. NarimatsuKazuhito WatanabeIkuo YamamotoHiroaki Yoshimura
    Citations (2)
    Inhibition of opioid-degrading enzymes potentiates Δ9-tetrahydrocannabinol-induced antinociception in mice
    Neuropharmacology (1998)
    Ignacio RecheMariano Ruiz–GayoJosé A. Fuentes
    Dynorphin
    DAMGO
    Naltrindole
    Thiorphan
    AM251
    Cannabinoid receptor antagonist
    Citations (24)
    Chronic Δ-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions
    Neuropharmacology (2000)
    Tiziana RubinoDaniela ViganòPaola MassiMaurizio SpinelloElisabetta Zagato
    Tetrahydrocannabinol
    Δ9-tetrahydrocannabinol
    Citations (73)
    Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
    European Journal of Pharmacology (1997)
    Thomas H. BurkeyRaymond M. QuockPaul ConsroeWilliam R. RoeskeHenry I. Yamamura
    Tetrahydrocannabinol
    Citations (61)
    The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
    European Journal of Pharmacology (2003)
    C. S. BreivogelSusan M. ScatesIrina O. BeletskayaOlivia B LoweryMario D. Aceto
    Rimonabant
    AM251
    Cannabinoid Receptor Agonists
    Citations (54)
    Involvement of serotonergic mechanisms in the inhibitory effect of U-50,488H on glutamate-induced lethality in mice.
    PubMed (1992)
    Junzo KameiH IgarashiYoshitoshi Kasuya
    The present study showed the involvement of serotonergic mechanisms in the protective effect of U-50,488H, a selective agonist of kappa-opioid receptors, against glutamate-induced lethality in mice. U-50,488H (1-10 mg/kg, i.p.) protected mice to a significant extent against glutamate-induced lethality, in a dose-related manner. This protective effect was not observed in p-chlorophenylalanine- or methysergide-treated mice. These results suggested that 5-HT in the brain may play an important role in the protective effect of U-50,488H against glutamate-induced lethality.
    Lethality
    Methysergide
    Citations (2)
    Changes in rat brain energetic metabolism after exposure to anandamide or Δ9-tetrahydrocannabinol
    European Journal of Pharmacology (2000)
    Barbara CostaMariapia Colleoni
    Anandamide
    Delta-9-tetrahydrocannabinol
    Cannabinoid receptor antagonist
    Rimonabant
    Citations (40)
    Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation
    European Journal of Pharmacology (2003)
    Nissar A. DarmaniLaura J. Sim‐SelleyBilly R. MartinJano J. JanoyanJennifer L. Crim
    Cannabinoid receptor antagonist
    Rimonabant
    Citations (42)